Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Quittner

Showing results (141-150 of 194) with videos related to

Pageof 20
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2011
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosaC E Wainwright, A L Quittner, D E Geller, et al.
Pediatric Pulmonology|July 31, 2010
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisChristopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care deliveryJ Abbott, J S Elborn, A M Georgiopoulos, et al.
Journal of Pediatric Psychology|January 26, 2010
Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosisKimberly A Driscoll, Suzanne Bennett Johnson, David Barker, et al.
Patient Education and Counseling|February 27, 2020
Misunderstandings, misperceptions, and missed opportunities: Perspectives on adherence barriers from people with CF, caregivers, and CF team membersCyd K Eaton, Sara Beachy, Katherine A McLean, et al.
Thorax|October 11, 2015
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxietyAlexandra L Quittner, Janice Abbott, Anna M Georgiopoulos, et al.
Respiratory Medicine|October 9, 2025
Mental health and transplantation in cystic fibrosisAnna M Georgiopoulos, Beth A Smith, Elisabeth P Dellon, et al.
Thorax|October 18, 2014
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scoresAlexandra L Quittner, Anne E O'Donnell, Matthias A Salathe, et al.
Pediatric Pulmonology|February 28, 2014
Tracking CF disease progression with CT and respiratory symptoms in a cohort of children aged 6-19 yearsLeonie A Tepper, Daan Caudri, Elisabeth M W J Utens, et al.
Annals of the American Thoracic Society|March 25, 2015
Adherence Determinants in Cystic Fibrosis: Cluster Analysis of Parental Psychosocial, Religious, and/or Spiritual FactorsDaniel H Grossoehme, Rhonda D Szczesniak, LaCrecia L Britton, et al.
Pageof 20

Showing results (141-150 of 194) with videos related to

Sort By:
Pageof 20
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 29, 2011
Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosaC E Wainwright, A L Quittner, D E Geller, et al.
Pediatric Pulmonology|July 31, 2010
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisChristopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 17, 2015
Cystic Fibrosis Foundation and European Cystic Fibrosis Society Survey of cystic fibrosis mental health care deliveryJ Abbott, J S Elborn, A M Georgiopoulos, et al.
Journal of Pediatric Psychology|January 26, 2010
Risk factors associated with depressive symptoms in caregivers of children with type 1 diabetes or cystic fibrosisKimberly A Driscoll, Suzanne Bennett Johnson, David Barker, et al.
Patient Education and Counseling|February 27, 2020
Misunderstandings, misperceptions, and missed opportunities: Perspectives on adherence barriers from people with CF, caregivers, and CF team membersCyd K Eaton, Sara Beachy, Katherine A McLean, et al.
Thorax|October 11, 2015
International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxietyAlexandra L Quittner, Janice Abbott, Anna M Georgiopoulos, et al.
Respiratory Medicine|October 9, 2025
Mental health and transplantation in cystic fibrosisAnna M Georgiopoulos, Beth A Smith, Elisabeth P Dellon, et al.
Thorax|October 18, 2014
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scoresAlexandra L Quittner, Anne E O'Donnell, Matthias A Salathe, et al.
Pediatric Pulmonology|February 28, 2014
Tracking CF disease progression with CT and respiratory symptoms in a cohort of children aged 6-19 yearsLeonie A Tepper, Daan Caudri, Elisabeth M W J Utens, et al.
Annals of the American Thoracic Society|March 25, 2015
Adherence Determinants in Cystic Fibrosis: Cluster Analysis of Parental Psychosocial, Religious, and/or Spiritual FactorsDaniel H Grossoehme, Rhonda D Szczesniak, LaCrecia L Britton, et al.
Pageof 20